Qingyi Tong

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 2

Top Topics

Inflammatory Response

Neoadjuvant Chemotherapy

Top Venues

Angewandte Chemie (International ed. in English)

Pharmaceuticals (Basel, Switzerland)

Sichuan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Sichuan University Sep 01 2009 - Jul 01 2014

China

PHD :: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital,

Publications

Jiaxiong Ming, Qianqian Xu, Limin Gao, Yanfang Deng, Jie Yin, Qun Zhou, Qingyi Tong, Yong-Hui Zhang
Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Hucheng Zhu, Chunmei Chen, Qingyi Tong, Jing Yang, Guangzheng Wei, Yongbo Xue, Jianping Wang, Zengwei Luo, Yong-Hui Zhang
Asperflavipine A: A Cytochalasan Heterotetramer Uniquely Defined by a Highly Complex Tetradecacyclic Ring System from Aspergillus flavipes QCS12. Angewandte Chemie (International ed. in English) 56 (19) (2017)